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Introduction 
Acute ution involves a myriad of cellular and 
humoral mechanisms which produce rapidly develop- 
ing increases in vascular permeability, changes in bl& 
BOW, and the mobilization, accumulation and activation 
of leukocytes, mainly neutrophils and monocytes. Re- 
cent work has ill uminaWl several important aspect5 of 
the acute inflammatory response which will be discussed 
here: (1) adhesive interactions between leukocytes and 
vascular endothelial cells; (2) leukocyte penetration of 
the bloed vessel wall; (3) leukocyte chemotaxis; (4) 
mechanisms of tissue injury, and (5) the overall biological 
role of cytokines in inducing some of these responses. 
Adhesive interactions between neutrophils and 
endothelial cells 
Neutrophil adhesion to the blood vessel wall is an early 
event in the infkunmatory response and is necessary for 
leukocyte accumulation within the inflammatoty site. 0.n 
the basis of in vitro studies, several mechanisms that 
could be responsible for mediating this critical interac- 
tion between neutrophils and blood vessel endothelial 
cells have been described (Fig. 1). 
Critical to understanding neutrophil-endothelial cell ad- 
hesive mechanisms in Mlammation is the idea that the 
speciíìcity of the reaction in vivo seems to reside in an al- 
tered endothelium. That is, neutrophils appear to adhere 
only to modifìed endothelium, rather than at random, as 
would be expected if neutrophil activation were the ini- 
tiator of adhesion. Recognition of this can be found in- 
some of the earliest studies in experimental pathology 
(Cohnheim, Lectures on General Pathology, New Syden- 
ham Society, 1889). Studies elucidating some of these 
changes in the endothelium have resulted in new insights 
into adhesive interactions. 
ElAh4-1 
The best understood mechanism of endothelial-based 
neutrophil-endothelial cell adhesion results from the 
synthesis of endothelial leukocyte adhesion molecule 
(ELAM)-1 by endothelial cells and its expression at their 
apical surface after activation of the endothelium by cy- 
tokines. ELAM-1 was identified using a panel of mon- 
oclonal antibodies raised against cytokine-treated endo- 
thelial cells. These were screened for their ability to 
bind selectively to activa&d endothelial cells and to in- 
hibit neutrophil adhesion to cytokine-activa& endothe- 
lial cells (Bevilacqua et aC, Proc NatlA& Sci USA 1987, 
84:923%9242). Use of the antibodies led to the defìnition 
of a molecule that could be immunoprecipitated from ac- 
tiva&d endothelial cells and the cloning of ELAM-1 from 
an endothelial complementary DNA (cDNA) library ex- 
pressed in COS cells [ll. A single transcript of 3.9 kb ap- 
pears to result in the translation of two peptides of similar 
molecular weight, probably Mering only in post-transla 
tional modiíìcations. The EIAM-1 molecule known to in- 
duce neutrophil adhesion on its own, as COS cells trans- 
fected with EIAM-1 are capable of binding neutrophils. 
The kinetics of transcription of ELAM-1 messenger RNA 
(mRNA), followed using the cloned cDNA, the appear- 
ante of protein in the endothelial cytoplasmic membrane 
detected with an antibody to ELAM1, and the induction 
of neutrophil adhesiveness following cytokine stimula- 
tion, are all consistent and show a significant induction at 
0.5 h, with activity peaking at 4-6 h and waning over 24 h. 
This also closely follows the kinetics of neutrophil accu- 
mulation in vivoafter cytokine administration and in in- 
flammatory responses generally. ELAIv-1 is induced on 
endothelial cells after treatment with the cytokines tumor 
necrosis factor (TNF)u, lymphotoxin (TNFB), and inter- 
leukin (IL)-lp, and also after endothelial cells have con- 
tacted bacterial endotoxin (Bevilacqua et al, Proc Natl 
Acad Sci USA 1987, 84:9238-9242). 
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Fig. 1. Schematic diagram of adhesion mechanisms documented in vitro that may be relevant to neutrophilendothelial adhesion oc- 
curring in acute inflammation. There are likely to be inter-relationships between these different mechanisms but their nature is 
unknown. ELAM, endothelial leukocyte adhesion molecule; ICAM, intercellular adhesion molecule; LFA, lymphocyte function-associated 
antigen; PAF, platelet-activating factor. 
The nucleotide sequence of ELAM-1 has revealed intrigu- 
ing relationships with other classes of proteins, including 
the lymphocyte homing receptor recognized by the MEL- 
14 antibody, the platelet and endothelial cell activation 
molecule, granule membrane protein 140 (GMP 140), 
and complement pathway regulatoty molecules. The sig- 
nifìcance of these relationships is currently unknown. 
Important questions about ELAM-1 include the nature of 
the neutrophil ligand for this molecule, whether ELAM-1 
is expressed on cell types besides the endothelium and 
whether stimuli other than cytokines and lipopolysaccha- 
ride will induce ELAM-1 expression. Although there is 
compelling evidente that ELAM-1 bas an important role 
in the acute infkunmatory response in vivo, this remains 
to be proven. 
CDllKD18 
There is evidente for the involvement of molecules 
other than ELAM-1 in adhesive interactions between 
neutrophifs and endothelial cells, most notabíy the 
CDll/CD18 group of leukocyte molecules. This topic 
was extensively reviewed last year [2]. Briefly, these 
three related heterodimers all share a common p-chain 
(CD18), and have unique a-chains (CDlla,b,c) linked 
non-covalently to the p-chain. CDlla is afso known as 
lymphocyte function-associated antigen (LFA)-1, CDllb 
is the type 3 complement receptor, and CDllc is 150/95 
or the type 4 complement receptor (Sanchez-Madrid et 
al., J Exp Med 1983, 158z1785-1803). There is consider- 
able in vitro and in vivo evidente linking these molecules 
to important adhesive interactions involving neutrophils, 
monocytes and lymphocytes, as well as evidente from 
an ‘experiment of nature’ [3,4]. The basis of the con- 
genital leukocyte adhesion deficiency syndrome is failure 
of expression of the CD1 l/CD18 complex; an important 
characteristic of this syndrome is neutrophil leukocytosis 
combined with inadequate neutrophil mobilization into 
sites of bacterial infection, strongly suggesting that neu- 
trophils require adequate expression of CDll/~~$l8 to 
cross the blood vessel wall. 
Experiments using monoclonaL antibodies leave lit- 
tle doubt that the CDll/CD18 complex of the neu- 
trophil has a significant role in adhesion of neutrophils 
to cytokine-stimulated endothelium, including a recent 
study of the rekttive signifïcance of the Em.1 and 
CD1 l/CD18 molecules [ 51. Partial inhibition of in vitre 
adhesion was caused by antibodies to EIAM-1 or by an- 
tibodies to CDlla, CDllb and CD18 after a 4-h expo 
sure of the endothelium to IL-1, with an addhive effect 
from combinations of EIAM-1 and CDll/CD18 antibod- 
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ies. The precise interactions, if any, between the neu- 
uophil CDll/CD18 molecules and the endothelial cell- 
asdted EIAM-1 molecule, which lead to intercellular 
adherente, remain to be identilíed. 
KAM-1 
Intercellular adhesion molecule (KAM)-1 is a widely dis- 
tnbuted cell surface molecule that mediates adhesive re- 
acnons and is a ligand for CDlla (LFA-1; MarlIn et al., 
Cel1 1987, 51:8X3-819). It is expressed at relat&ely low 
1evel.s on untreatd endothelial cells and is markedly up- 
regulated by cytokines (Pober et al, J Immunoll986, 
137:18931896). On the basis of the use of antibodies 
to KAM-1, it seems that this molecule is involved in the 
adhesion of neutrophils to cytokine-treated endothelial 
cells [6]. Another ligand for LFA-1, KAM-2, has recently 
been characterized and its role, if any, in these reactions 
is unknown [71. 
Mechanisms of rapidly induced adhesion 
It is unlikely that neutrophil adhesion to endothelial 
cells previously exposed to cytokines represents the 
sole adhesion mechanism in acute inflammation. Neu- 
trophil adhesion to endothelial cells can occur very 
rapidly (within minutes) after injuty (Allison et al., J 
Ezxp Med 1955, 102:655-668; Atherton et al, J Pbpbl 
1972, 222~447-474). Cytokine-media& adhesion involv- 
ing transcription, translation, post-translational events, 
and membrane insertion of the newly synthesized pro- 
tein( requires a minimum of 0.5 h to become de- 
tectable and only becomes prominent after 1-2 h. Two 
adhesion mechanisms with a rapid onset may be relevant 
to very early adhesive interactions between neutrophils 
and endothelial cells. 
Approptiately stimulated endothelial cells produce the 
phospholipid platelet-activating factor (PAF). Endothe- 
lial cell-generated PAF or exogenous PAF will induce 
neutrophil-endothelial adhesion @immerman et dl, J 
Clin Invest 1985, 76:223%2246). The adhesion is de- 
tectable after 1 min, peaks at 5 min, and rapidly wanes 
thereafter. Thrombin is able to stimulate PAF production 
in endothelial cells, suggesting that there is a nexus be 
tween platelets, the coagulation cascade and the inham-, 
matory response. Interestingly, thrombin-stimulated ad- 
hesion does not seem to depend on CD18 molecules to 
any marked extent [8]. 
An adhesion mechanism that depends on complement 
hxation on the endothelium has recently been dehned 
[9]. The complement system is a humoral cascade ca- 
pable of rapid amplihcation and is well known to lx 
involved in many inflammatory processes. Complement 
lìxation on endothelial cells leads to neutrophil adhe- 
sion within 1 min of complement activation, with adhe- 
sion peaking at 20min. The adhesion is maintained as 
long as a source of complement is available. This adhe- 
sion requires no components distal to C3 (i.e C5-49) 
and is mediated by the complement activation product 
iC3b, which is lïxed to the endothelial cell and func- 
tions as a bridge to the type 3 complement receptor 
(CDllb/CD18) on the neutrophil. This adhesive mech- 
anism provides a clear role for the involvement of neu- 
trophil CDllb/CDlS binding to a known ligand. 
Leukocyte penetration of the vascular wal1 
Following attachment, the neutrophil must cross the 
blood vessel wall and then the subendothelial extracel- 
lular matrix to gain access to the extra-vascular compart 
ment. Recent studies using tissue culture models of the 
vessel wall have provided some interesting and novel re- 
sults. 
The cytokines TNF and II-1, apart from causing adhe- 
sion, also causa neutrophils to migrate through a con- 
fluent endothelial cell monolayer [ 101, independently of 
a chemotactic gradient. The endothelial cell response to 
the cytokine requires protein synthesis and is due to an 
activity associated with the apical surface of the endothe- 
lium. This migration is not a simple sequelae to adhesion, 
since adhesion induced by other means (FC interactions) 
is not associated with migration. The molecular basis of 
this rnigration is entirely unknown. 
A recent study investigated the next event in neutrophil 
transport into an imlammatoty focus, namely migra- 
tion through the extracellular matrix (vascular basement 
membrane) [ 111. This endothelial matrix normally forms 
an impermeable banier. Once neutrophils have migrated 
beyond the endothelium, they cross the subendothelial 
extracellular matrix in a way that is associated with its 
local physical disruption as defined by increasing perme- 
ability of the matrix to colloids, by an as yet unknown 
mechanism. After the neutrophil has passed through the 
matrix, the endothelial cell brings about a resealing of 
the vascular basement membrane by a process requiring 
protein synthesis that is presumably related to the gener- 
ation of new basement membrane components. 
Leukocyte chemotaxis 
Many molecules are capable of causing the migration of 
phagocytes along a concentration gradient and these have 
been assumed to be important in attraction to the sites 
of inllammatory foei. Recently, new families of peptide 
chemotaxins, which are likely to be of major signiIîcance 
as physiological mediators of chemotaxis, have been de- 
lïned. 
The appearance of phagocytes in inllarnmatory lesions is 
characterized by marked differences in the time course 
of accumulation of the various cell types (Wilhelm. Zn 
Pathology edited by Anderson and Kissane. Mosby, 1977, 
pp 2589). The molecular basis for this heterogene- 
ity was, until recently, unexplained, but there is now 
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strong evidente for the existente of cell type-speciiíc 
chemotactic signals. A peptide, neutrophil chemotactic 
factor (NCF), was purified from activated macrophages 
(Yoshimura et al, Proc Nat1 Acad Sci USA 1987, 
84:92359237), cloned and sequenced [12]. It is one 
member of a family of small peptides and is a po 
tent neutrophil chemotaxin and activator. NCF has tar- 
get speciiìcity in that it has no effect on macrophages. 
A macrophage-specifïc (and neutrophil-inactive) chemo- 
taxin has also recently been identiiïed [13]. Although 
these factors have been characterized from macrophages 
and cell lines, it is now known that they are also pro- 
duced by endothelial cells [ 141 as well as other cellular 
constituents of nomral tissues. It is likely that endothelial 
cells as well as other cells represent an important source 
of chemotaxins for the acute Mlamrnatory response. 
Mechanisms of tissue injury 
Until recent& thinking about the mechanisms by which 
phagocytes cause tissue damage has evolved in two sep- 
arate fields, oxidants derived from activity of the plasma 
membrane oxidase for reduced nicotinamide adenine 
dinucleotide phosphate (NADPH), and proteinases re- 
leased from cytoplasmic granules. There is little doubt 
that phagocyte cell-derived oxidants including superox- 
ide ions, hydrogen peroxide, hypochlorous acid, and the 
hydroxyl radical are toxic to cells and tissues, resulting in 
cell damage or death, increases in vascular permeability, 
fibrosis and amplihcation of the intlammatoty response 
by mechanisms such as the generation of chemotactic 
lipids (Warren et al, Patbol Immuncpatbol Res 1987, 
6301-315). Proteinases derived from phagocytes, while 
not directly toxic to cells, can bring about hydrolysis of 
proteins, resulting in tissue disruption. 
Recent results have led to an ecumenical view that both 
oxidants and granule enzymes function in a synergistic 
marmer to produce the complete toxic capacity of the 
neutrophil [15]. For example, oxidants are capable of 
blocking the anti-proteinase activity of blood, allowing 
proteinase activity to become manifest. Chlorinated oxi- 
dan&, (e.g. HOCl) are also capable of converting the la- 
tent farms of collagenase (Wiess et al, Science 1985, 
227:747-749) and gelatinase (Peppin et al, Proc Nat1 
Acad Sci USA 1986, 83:4322-4326) into active enzymes. 
Exposure of the basement membrane to oxidants ren- 
ders it more susceptible to attack by leukocyte proteases 
(Vissers et al, Bkxhem Bicp&Acta 19s6,889:277-286). 
Thus, the way in which products of activated phagocytic 
cells cause tissue injury is considerably more complex 
than previously realized. 
Cytokines 
It is apparent from the above discussion that cytokines 
such as TNF and 11-1 have important effects on tissue 
constituents, such as endothelial cells, and produce multi- 
ple reactions responsible for the accumulation of phago- 
cytes in inflammatory lesions. Evidente is accumulating 
that cytokines have other potent pro-inflammatory effects. 
cytokines can ‘prime’ macrophages for enhanced oxy 
gen radical production [ 161. Their introduction into or- 
gans reproduces the acute inflammatory response, with 
permeability changes and accumulation of neutrophils 
[ 17,181. Combinations of cytokines have synergistic ef- 
fects in vivo [ 191. Perhaps the most important and direct 
evidente for the role of cytokines in the acute inIlamma- 
toty response comes from the discovery that antibodies 
to TNF will ameliorate the acute inflammatory response 
caused by deposition of immune complexes in the lung 
(Warren et al. J Clin Znvest, in press). Although this does 
not exclude a role for other mediators, as yet undiscov- 
ered, it is compelling evidente that cytokines have an 
important role in the development of inllammatoty re- 
actions. 
~nitial work showed that cytokines are produced by 
macrophages, but more recently it has emerged that they 
may be produced by a variety of cell types. Some of these, 
such as endothelial cells (Libby et al, Am J Patbol 1986, 
124:179-185) mast cells [20] and smooth muscle cells 
[21] (Wamer et al, JEqD Med 1987,165:131&1331), are 
present close to sites of acute inflammation, suggesting 
that there is a broad repertoire of cells that can contribute 
to the pathogenesis of the acute inllammatoty reaction. 
Summary 
A major theme in current developments in this field has 
been the realization that the target tissue, in particular 
the endothelium, has an active role in initiating and par- 
ticipating in inflammatory reactions and is not a passive 
target, as was previously thought. Attempts to delineate 
the mechanisms involved have benefited immeasurably 
from the application of the modem techniques of molec 
ular and cellular biology, and will continue to do so. It 
is axiomatic that a fuller understanding of these mech- 
anisms w%ll result in the development of new strategies 
designed to black the acute Mlammatory response more 
speciiïcally and effectively. 
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